Critical Pathways: The Role of Pharmacy Today and Tomorrow

  • Dobesh, Paul P. Pharm.D., FCCP
  • Bosso, John Pharm.D., FCCP
  • Wortman, Suzanne Pharm.D.
  • Dager, William E. Pharm.D., FCSHP
  • Karpiuk, Emilie L. Pharm.D., Qing Ma, Ph.D.
  • Zarowitz, Barbara J. Pharm.D., FCCP

This document was prepared by the 2005 ACCP Task Force on Critical Pathways: Paul Dobesh, Pharm.D., FCCP, BCPS, Chair; Doug Baldwin, Pharm.D.; John Bosso, Pharm.D., FCCP, BCPS; Timothy Clifford, Pharm.D.; William Dager, Pharm.D.; Emilie Karpiuk, Pharm.D., BCOP, BCPS; Qing Ma, Ph.D.; and Suzanne Wortman, Pharm.D., BCPS. Approved by the ACCP Board of Regents on January 25, 2006; final revision received on December 19, 2005.

Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 650, Kansas City, MO 64111; e-mail: [email protected]; or download from http://www.accp.com.

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 26(9):p 1358-1368, September 1, 2006.
Copyright © 2006 John Wiley & Sons, Inc.